RIL
LENZ

Rothschild Investment LLC’s LENZ Therapeutics LENZ Stock Holding History

Rothschild Investment LLC’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$392 Sell
69
-111
-62% -$895 ﹤0.01% 3320
2026
Q1 		$1.65K Buy
180
+178
+8,900% +$2.5K ﹤0.01% 2646
2025
Q4 		$32 Sell
2
-18
-90% -$525 ﹤0.01% 3305
2025
Q3 		$932 Hold
20
– – ﹤0.01% 2610
2025
Q2 		$586 Buy
+20
New +$544 ﹤0.01% 2689

Other funds holding LENZ

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
KFA
Kelleher Financial Advisors New York $705M AUM 16.14% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

Rothschild Investment LLC's LENZ Position: Q2 2026 in Review

Rothschild Investment LLC reduced its LENZ Therapeutics (LENZ) stake by 62% in Q2 2026, selling an estimated $895 and leaving 69 shares worth $392. The position accounts for ﹤0.01% of the portfolio, ranked #3320.

Rothschild Investment LLC first reported a position in LENZ in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.65K in Q1 2026. 33 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Rothschild Investment LLC held 69 shares of LENZ Therapeutics worth $392 as of Q2 2026.
  • Rothschild Investment LLC sold 111 LENZ Therapeutics shares in Q2 2026, an estimated $895.
  • LENZ Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3320 holding.
  • Rothschild Investment LLC first reported a position in LENZ Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Rothschild Investment LLC's LENZ Therapeutics position peaked at $1.65K in Q1 2026.
  • 33 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.